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ABSTRACT
Background: Pseudomonas aeruginosa is a bacterium that belongs to the microbiota of snakes, but it may also be an 
opportunistic pathogen and contaminate humans through fecal contact, bites, and injuries. In snakes, this microorganism 
may present high pathogenicity at certain conditions and have been associated with high morbidity and mortality. Reports 
of infection of Boa constrictor by this pathogen are rare. Thus, this study aimed to describe the P. aeruginosa oral infec-
tion in a snake specimen (Boa constrictor amarali), approaching the isolation and identification of the infectious agents 
involved, the antimicrobial sensitivity and resistance, and the therapeutic protocol adopted.
Case: A free-living adult female specimen of Boa constrictor amarali (Amaral’s boa), with no described previous his-
tory was rescued in an urban area by the Environmental Police. Clinical evaluations showed structures of caseous aspect 
in the oral cavity, with hyperemia spots in the mucosa. Samples of these lesions were sent for mycological examination, 
and fungal forms were not found. Samples were collected for isolation and culture. The antimicrobial susceptibility of the 
isolated microorganisms was determined by the modified Kirby-Bauer disk diffusion method. P. aeruginosa was isolated 
and showed susceptibility to amikacin, gentamicin, and polymyxin-B; intermediate susceptibility to azithromycin, and cip-
rofloxacin; and resistance to cephalexin, ceftiofur, chloramphenicol, and enrofloxacin. The treatment consisted of cleaning 
of the oral cavity, local infiltration of lidocaine for debridement of the caseous area that were later cauterized with iodine. 
Systemic antibiotic therapy was used, with intramuscular administration of amikacin (5 mg/kg) for the first dose and (2.5 
mg/kg) for the other doses with intervals of 72 h, and oral administration of metronidazole (20 mg/kg) with intervals of 
48 h, both during 21 days. Daily subcutaneous fluid therapy was performed as support treatment, using Lactated Ringer’s 
solution (25 mg/kg) and Vitamin C (10 mg/kg) with intervals of 24 h, being the cure observed at the end of treatment.
Discussion: This paper presents the pathological findings of the Pseudomonas aeruginosa oral infection in a B. constrictor 
amarali. This bacterium is an opportunistic pathogen that is commonly found in snakes, thus, humans in contact with these 
animals may be contaminated with this pathogen. However, oral cavity lesions associated with P. aeruginosa had not yet 
been related to Boa constrictor amarali, which is a non-venomous species. Few bacteria associated with reptile diseases 
are primary causative agents. Clinical bacterial infections generally tend to be secondary to viral infections. Predisposing 
factors for the development of bacterial diseases in these reptiles include immunodepression, malnutrition, poor adaptation 
to captivity, and the maintenance of these animals at temperatures and humidities outside their thermal comfort range. In 
the present study, the P. aeruginosa behaved as an opportunistic pathogen, resulting in clinical manifestations with case-
ous lesions in the oral cavity, probably due to an imbalance of the microbiota caused by stress or immunodepression. The 
antibiogram allowed the adoption of a correct therapeutic protocol based on the susceptibility of the pathogen, resulting 
in remission of lesions and clinical signs after 21 days of treatment.
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INTRODUCTION
Boa constrictor amarali is a non-venomous 
snake of the Squamata order (Ophidia suborder) that 
is widely distributed in the Brazilian territory [9], 
especially in the Northeast, Southeast, and South 
regions [7].
Infectious diseases are the main causes of mor-
tality of snakes, mainly by Gram negative microorga-
nisms. The predominance of these bacteria in infectious 
processes is directly connected to the opportunistic 
character of the normal bacterial microbiota of the 
host, especially in infections caused by Pseudomonas 
sp., Aeromonas hydrophila, Proteus sp., Salmonella 
sp., Citrobacter sp., Escherichia coli, Providencia sp. 
and Xanthomonas maltophila [9].
Reptiles host important zoonotic microorganis-
ms, such as the bacterium Pseudomonas aeruginosa, 
therefore, humans can be contaminated with these mi-
croorganisms through fecal contact, bites, and injuries 
[4]. Pseudomonas spp. may present high pathogenicity 
at certain conditions and have been associated with 
high morbidity and mortality in infected animals due 
to their ability to develop resistance to antibiotics and 
express multiple virulence factors [14].
P. aeruginosa can be isolated from samples 
of diseased and healthy reptiles. The first cases of 
cross contamination between snakes and their healthy 
owners have been reported recently [1]. P. aeruginosa 
is a microorganism that belongs to the microbiota of 
reptiles, especially in their oral cavity and intestinal 
tract; however, it can be an opportunistic pathogen 
with several clinical manifestations in susceptible 
animals [2].
CASE
A free-living adult female specimen of Boa 
constrictor amarali (Amaral’s boa), with no described 
previous history was rescued in an urban area by the 
Environmental Police and taken to the Laboratory of 
Teaching and Research in Wild Animals of the Veteri-
nary Hospital of the Federal University of Uberlândia 
(VH-UFU), Minas Gerais, Brazil. The animal was 
weighed in a digital scale and presented 3.2 kg.
The clinical evaluation showed dehydration 
signs, and presence of caseous structures in the oral 
cavity, in the upper-left, upper-right, and lower-right 
tooth regions, with hyperemia spots in the mucosa 
(Figure 1A). Samples of these lesions were collected 
and sent to the Veterinary Clinical Laboratory of the 
VH-UFU for mycological examination. This material 
was placed in slides and analyzed in an optical light 
microscope (10x and 40x objective) using tow drops 
of 10% potassium hydroxide (Anidrol®)1 to clear the 
sample, but fungal forms were not found.
Samples were collected by passing a sterilized 
alginate cotton tip swab through the entire lesion. The 
sample was stored in a plastic tube containing a semi-so-
lid transport medium Stuart (Absorve®)2 and sent to the 
Laboratory of Infectious Diseases of UFU. The sample 
was then transferred to a tube containing Thioglycolla-
te broth (Himedia®)3 - a highly nutritive medium that 
helps the growth of microorganisms - and incubated in 
a bacteriological oven at 37°C for 24 h [12].
Samples were plated for bacterial isolation 
on one Petri dish containing blood agar and other 
containing MacConkey agar (TM Media®)4, using the 
streaking technique with a platinum inoculating loop. 
These dishes were placed in a bacteriological oven at 
37°C for 24 h for incubation [16]. Gram staining was 
carried out to identify gram-positive and gram-negative 
bacteria in the blood agar (Kasvi®)5 colonies.
Colonies grown on MacConkey4 agar were 
identified through biochemical tests in the mediums 
phenol red, lysine, phenylalanine, citrate, urea, and 
SIM (sulfide, indole, motility), screening colonies that 
grow on selective medium for gram-negative bacteria 
of the Enterobacteriaceae family. A medium was 
used for each different colony grown on MacConkey4 
agar to identify each bacterial genus or species. The 
oxidation-fermentation test was included for colonies 
of gram-negative bacteria that were not of the Entero-
bacteriaceae family.
Figure 1. Oral cavity of a specimen of Boa constrictor amarali with caseous 
stomatitis. A- Presence of caseous structures in the upper-left (white arrow), 
upper-right (red arrow), and lower-right (black arrow) tooth regions, with 
hyperemia spots in the mucosa (circles). B- Absence of caseous lesions and 
hyperemia spots in the mucosa after 21 days of treatment.
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Colonies of Pseudomonas spp. grew on Mac-
Conkey agar medium4; these bacteria were identified 
by their colony morphology and typical odor. Bio-
chemical tests confirmed this genus and identified the 
bacterium species Pseudomonas aeruginosa.
The antimicrobial susceptibility of the isola-
ted microorganisms was determined by the modified 
Kirby-Bauer disk diffusion method [12]. The isolates 
were inoculated in Mueller Hinton (Kasvi®)5 broth 
and incubated at 37°C until showing turbidity of 0.5 
according to the Mac Farland scale. The isolates were 
streaked on Petri dishes containing Muller Hinton agar 
medium, using a swab. Subsequently, the antimicrobial 
drugs enrofloxacin, ciprofloxacin, amikacin, ceftiofur, 
gentamicin, chloramphenicol, azithromycin, polymy-
xin-B, and cephalexin (Laborclin®)6 were applied to 
the impregnated discs [9]. They were then incubated 
in an oven at 37ºC for 24 h and the formed halos were 
evaluated to determine the susceptibility profile of the 
isolated pathogens.
P. aeruginosa presented susceptibility to ami-
kacin, gentamicin, and polymyxin-B; intermediate 
susceptibility to azithromycin, and ciprofloxacin; and 
resistance to cephalexin, ceftiofur, chloramphenicol, 
and enrofloxacin.
The treatment consisted of cleaning of the oral 
cavity with 0.9% saline solution (0.9% Saline)7 and 
oral 2.0% chlorhexidine (Riohex®)8, local infiltration 
of 2.0% lidocaine (Xylestesin®)9 for debridement of the 
caseous lesions, and cauterization of the lesions with 
iodine (Riodeine®)8. Local cleaning and cauterization 
with iodine were performed daily at lesion sites.
Based on the antimicrobial susceptibility tes-
ting (AST) and according to Klaphake [8], amikacin 
(Amicilon®)10 was administered intramuscularly (5 
mg/kg) for the first dose and 2.5 mg/kg for the other 
doses with intervals of 72 h, combined with oral admi-
nistration of metronidazole [Benzoilmetronidazol11 at 
dose of 20 mg/kg with intervals of 48 h], both during 
21 days. Metronidazole11 can be given simultaneously 
with amikacin10 for a larger spectrum.
Daily subcutaneous fluid therapy was perfor-
med as support treatment, using Lactated Ringer’s9 
solution (25 mg/kg) and Vitamin C [Monovin C®12 
- 10 mg/kg] with intervals of 24 h [8]. Vitamin C can 
be a coadjutant in cases of stomatitis and cutaneous 
conditions, and a supportive therapy for bacterial 
infections. Remission of lesions and clinical signs 
was observed after 21 days of treatment (Figure 1B).
The animal remained under controlled tem-
perature of 30°C throughout the treatment for better 
metabolism of the drugs.
DISCUSSION
Infectious agents can be transmitted to snakes 
through wounds caused by trauma, and contact with 
contaminated environments, handlers, and utensils. 
However, immunodepression, malnutrition, poor 
adaptation to captivity, and the maintenance of these 
animals at temperatures and humidities outside their 
thermal comfort range are considered predisposing fac-
tors for the development of bacterial diseases in these 
reptiles [15]. However, few bacteria associated with 
reptile diseases are primary causative agents. Clinical 
bacterial infections generally tend to be secondary to 
viral infections [8].
Pseudomonas spp. belong to the microbiota 
of snakes, especially in their oral cavity [4,6,17]. 
However, in conditions of high pathogenicity, clini-
cal manifestations and lesions can develop in their 
oral cavity and even in other organs [4,11,18]. In the 
present study, the P. aeruginosa behaved as an oppor-
tunistic pathogen, resulting in clinical manifestations 
with caseous lesions in the oral cavity, probably due 
to an imbalance of the microbiota caused by stress or 
immunodepression.
P. aeruginosa has been isolated from skin 
vesicles of a coral snake (Micrurus corallinus), scales 
with caseous content of a sucuri snake (Eunectes mu-
rinus) [5], and subcutaneous nodules of a boa snake 
(Boa contrisctor amarali) [11]. However, oral cavity 
lesions associated with P. aeruginosa had not yet been 
related to Boa constrictor amarali, which is a non-
-venomous species.
P. aeruginosa is an opportunistic pathogen for 
animals and humans, associated with high morbidity 
and, sometimes, high mortality. Studies have shown 
that captive reptiles have been carriers of P. aeruginosa, 
thus, they are sources of contaminations for humans 
who interact with these animals [3,4].
P. aeruginosa from skin lesions of snakes 
was isolated in previous studies and was observed 
resistance to all antibiotics tested in the AST; even 
with the establishment of systemic and topical anti-
biotic therapy, 90.9% of the animals died, denoting 
the multiresistance of the isolated agents [5]. Cases 
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of multiresistant bacteria isolated from reptiles has 
been reported [11,13,19], showing the limitation of the 
therapeutic protocols adopted [5] and the need of AST 
to determine the susceptibility or resistance profile 
of these agents to avoid resistances to antimicrobials.
In the present study, the pathogen evaluated 
was not resistant to all antimicrobials tested, but it was 
resistant to cephalexin, ceftiofur, chloramphenicol 
and enrofloxacin; moderately resistant to azithromy-
cin, and ciprofloxacin; and susceptible to amikacin, 
gentamicin, and polymyxin-B. The AST allowed the 
adoption of a correct therapeutic protocol, based on 
the susceptibility of the microorganism, resulting in 
remission of lesions and clinical signs after 21 days 
of treatment.
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